Erlinda Maria Gordon, M.D
Erlinda Maria Gordon, M.D., is an experienced Pediatric Hematologist-Oncologist, cancer drug developer, biopharmaceutical founder and executive with Cancer Center of Southern California. She has a proven track record in translational biomedical research, patient care and cancer drug development.
A Diplomate of the American Board of Pediatric Hematology/Oncology, Dr. Gordon was a Tenured Associate Professor for 24 years and is a Professor Emeritus at the USC Keck School of Medicine, Los Angeles, California. She is co-inventor of more than 150 patents in biomedical research, and patented the first targeted gene delivery system for cancer in the USA, Europe and the Philippines. She has authored more than 100 original peer-reviewed articles and served as Editor-in-Chief of the International Journal of Pediatric Hematology-Oncology, Director of the Red Cell Defects Program and the NIH-funded Comprehensive Hemophilia Center at Childrens Hospital of Los Angeles and the NIH-funded Children’s Oncology Group. Dr. Gordon was co-founder of two biotechnology companies and is a pioneer in the development of targeted gene therapy products. In her position as FDA liaison for these companies, Dr. Gordon gained FDA orphan drug approval and fast track designation for pancreatic cancer, soft tissue sarcoma and osteosarcoma and accelerated approval for Rexin-G, the world’s first targeted genetic medicine for cancer. At USC, Dr. Gordon licensed the First Academic Vector Production Unit at the Norris Comprehensive Cancer Center, served as its first Medical Director for eight years, and was the Gene Therapy Sponsor for clinical protocols using Targeted Genetic Medicines for Cancer. Dr. Gordon was recipient of the Los Angeles Award for Excellence in Biotechnology Research, the National Institutes of Health Research Career Development Award and NIH/FDA funded grant awards.
Currently, Dr. Gordon serves as the Director of Biological and Immunological Therapies and the Chairman of the NIH-approved Institutional Biosafety Committee at the Sarcoma Oncology Center in Santa Monica, California.
A native of the Philippines and an alumna of the University of Santo Tomas Medical College of Medicine and Surgery, where she received her medical degree, Dr. Gordon is nominee for the prestigious Thomas Award for Excellence in Research to be awarded in 2016.
Click here for Dr. Gordon’s CV.
Next, read about Dr. Rekha Baby.